About Kincell Bio
Kincell Bio is a company based in Gainesville (United States) founded in 2023. Kincell Bio has raised $58 million across 2 funding rounds from investors including NewSpring Capital and Kineticos. Kincell Bio offers products and services including Analytical Development, Process Development, and cGMP Manufacturing. Kincell Bio operates in a competitive market with competitors including Blue Rock Therapeutics, Impel Pharmaceuticals, CellCarta, Ascend and RiboPro, among others.
- Headquarter Gainesville, United States
- Stage Minicorn
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$58 M (USD)
in 2 rounds
-
Latest Funding Round
$22 M (USD), Series A
May 15, 2025
-
Investors
NewSpring Capital
& 1 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Kincell Bio
Kincell Bio offers a comprehensive portfolio of products and services, including Analytical Development, Process Development, and cGMP Manufacturing.
Expert testing for cell therapy quality and consistency.
Strategies to optimize cell therapy processes.
Efficient production of cell therapies to high standards.
Funding Insights of Kincell Bio
Kincell Bio has successfully raised a total of $58M across 2 strategic funding rounds. The most recent funding activity was a Series A round of $22 million completed in May 2025. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Kincell Bio
Kincell Bio has secured backing from 2 investors, including venture fund and institutional investors. Prominent investors backing the company include NewSpring Capital and Kineticos.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Investment firm focusing on lower-middle market growth, healthcare, and various strategies.
|
Locked | Locked | Locked | |
|
Invests in early-stage life sciences companies for innovation, expertise, and growth.
|
Locked | Locked | Locked |
Investor details for Kincell Bio
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Kincell Bio
Investment portfolio details for Kincell Bio
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Kincell Bio
Detailed financials for Kincell Bio
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Kincell Bio Comparisons
Peer comparison for Kincell Bio
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Kincell Bio
Kincell Bio operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Blue Rock Therapeutics, Impel Pharmaceuticals, CellCarta, Ascend and RiboPro, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Stem cell therapies are developed for cardiovascular and neurological diseases.
|
|
| Locked | Locked | Locked |
Transformative therapies are developed and commercialized through specialized services.
|
|
| Locked | Locked | Locked |
Histopathology and genomics services are offered by the CRO.
|
|
| Locked | Locked | Locked |
Online insurance payments and premium financing are enabled for businesses.
|
|
| Locked | Locked | Locked |
Online supplier and developer of RNA based products
|
|
| Locked | Locked | Locked |
Stem cell drug research and clinical trial services are provided.
|
Detailed competitors of Kincell Bio
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Kincell Bio
Complete news archive for Kincell Bio
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Kincell Bio
Kincell Bio was founded in 2023.
Kincell Bio is headquartered in Gainesville, United States.
Kincell Bio is a funded company, having raised a total of $58M across 2 funding rounds to date.
Kincell Bio, led by Bruce Thompson as CTO, specializes in providing healthcare solutions, biopharma outsourcing, diversified, and cell gene therapy. Provider of clinical cell therapy development manufacturing and consulting services. The team drives innovation, quality service, and sustainable practices to achieve excellence and client satisfaction.
Kincell Bio's top competitors include Blue Rock Therapeutics, Ascend and CellCarta.
Kincell Bio offers Analytical Development, Process Development, and cGMP Manufacturing.
Kincell Bio has 2 investors. Key investors include NewSpring Capital, and Kineticos.
The valuation of Kincell Bio is $66M as of Jul 2023.